Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Stereotactic Radiotherapy System Approved For BC

FDA news release; 2017 Dec 22

Publish date:: January 2, 2018

The FDA has approved a new noninvasive stereotactic radiotherapy system to treat cancer in breast tissue.

Indications: The GammaPod system is intended for use in the noninvasive stereotactic delivery of a radiation dose to a portion of the breast in conjunction with breast conserving treatment.

Administration: The system uses thousands of focused beams of radiation from 36 rotating radioactive Cobalt-60 sources in combination with a 2-layer, vacuum-assisted cup that immobilizes the breast to achieve a more accurate delivery of radiation.

Efficacy and safety: Approval is based on a study of 17 individuals that showed the prescribed dose was delivered to the breast tumor with minimal radiation-induced side effects such as skin redness or erythema.

Citation:

FDA clears stereotactic radiotherapy system for use in treating breast cancer [news release]. Silver Spring, MD: FDA. December 22, 2017. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm590313.htm?utm_campaign=12222017_PR_FDA%20clears%20stereotactic%20system&utm_medium=email&utm_source=Eloqua. Accessed December 31, 2017.

This Week's Must Reads

Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa ,

Utilization of Surgery for Post-prostatectomy Incontinence,

Claims Analysis of Advanced PCa Treatment Costs and Resource Use,

Testosterone Therapy Doesn't Increase Prostate Cancer Risk,

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa,

Must Reads in Breast Cancer

Increased Cancer Death Linked to Radioactive Iodine Therapy,

Bioimpedance Spectroscopy May Better Identify Lymphedema Progression,

Stereotactic Radiotherapy System Approved For BC, FDA news release; 2017 Dec 22

Perjeta Approved for Certain Type of Early BC, Genentech news release; 2017 Dec 20

Cochrane on Bisphosphonates for Breast Cancer, Cochrane; 2017 Oct 30; O'Carrigan, Wong, et al